MapLight Therapeutics MPLT
NASDAQ MPLT
$7.44 +0.16 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Preferred Stock Liabilities (2024 - 2025)

Updated

MapLight Therapeutics (MPLT) reported Preferred Stock Liabilities of $507.69 million for Q3 2025, up 64.4% from $308.82 million a year earlier and up 64.4% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

At the end of FY2024, MapLight Therapeutics posted Preferred Stock Liabilities of $308.82 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 507.69 Mn
Jun 30, 2025 308.82 Mn
Mar 31, 2025 308.82 Mn
Dec 31, 2024 308.82 Mn
Sep 30, 2024 308.82 Mn
API Access

MapLight Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=MPLT&period=max&api_key=YOUR_API_KEY